X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3153) 3153
science & technology (2901) 2901
female (2894) 2894
life sciences & biomedicine (2624) 2624
breast cancer (2145) 2145
oncology (1790) 1790
triple negative breast neoplasms - pathology (1635) 1635
triple negative breast neoplasms - metabolism (1564) 1564
cell line, tumor (1437) 1437
triple negative breast neoplasms - genetics (1029) 1029
middle aged (1008) 1008
animals (992) 992
triple negative breast neoplasms - drug therapy (911) 911
cancer (872) 872
adult (809) 809
breast neoplasms - metabolism (790) 790
triple-negative breast cancer (783) 783
prognosis (780) 780
mice (731) 731
breast neoplasms - pathology (723) 723
aged (689) 689
receptor, erbb-2 - metabolism (630) 630
gene expression (586) 586
metastasis (579) 579
gene expression regulation, neoplastic (573) 573
receptors, estrogen - metabolism (569) 569
tumors (561) 561
cell biology (552) 552
receptors, progesterone - metabolism (482) 482
analysis (474) 474
immunohistochemistry (472) 472
chemotherapy (455) 455
apoptosis (450) 450
biomarkers, tumor - metabolism (408) 408
cell proliferation - drug effects (405) 405
research (385) 385
antineoplastic agents - pharmacology (384) 384
xenograft model antitumor assays (381) 381
triple negative breast cancer (379) 379
signal transduction (374) 374
proteins (368) 368
cell proliferation (363) 363
care and treatment (354) 354
health aspects (352) 352
medical prognosis (344) 344
cancer therapies (343) 343
research article (340) 340
breast neoplasms - genetics (338) 338
medicine & public health (329) 329
apoptosis - drug effects (323) 323
biochemistry & molecular biology (321) 321
breast neoplasms - drug therapy (320) 320
neoplasm staging (313) 313
mice, nude (308) 308
aged, 80 and over (304) 304
triple negative breast neoplasms - mortality (285) 285
genetic aspects (282) 282
science & technology - other topics (271) 271
development and progression (268) 268
pathology (263) 263
metastases (260) 260
kinases (254) 254
epidermal growth factor (253) 253
antineoplastic agents - therapeutic use (248) 248
signal transduction - drug effects (242) 242
retrospective studies (234) 234
multidisciplinary sciences (231) 231
disease-free survival (230) 230
mcf-7 cells (228) 228
estrogen (226) 226
medicine (226) 226
neoplasm metastasis (224) 224
treatment outcome (219) 219
neoplasm invasiveness (215) 215
stem cells (213) 213
skin and connective tissue diseases (209) 209
cell survival - drug effects (206) 206
cancer research (204) 204
gene expression regulation, neoplastic - drug effects (204) 204
breast neoplasms - mortality (202) 202
research paper (200) 200
antineoplastic combined chemotherapy protocols - therapeutic use (197) 197
kaplan-meier estimate (197) 197
mice, inbred balb c (197) 197
triple negative (197) 197
medicine, research & experimental (194) 194
mutation (194) 194
research & experimental medicine (194) 194
cell cycle (193) 193
triple negative breast neoplasms - therapy (192) 192
biomarkers, tumor - genetics (191) 191
pharmacology & pharmacy (191) 191
gene expression profiling (184) 184
biomarkers (181) 181
phosphorylation (179) 179
progesterone (179) 179
micrornas - genetics (168) 168
studies (168) 168
science (167) 167
triple negative breast neoplasms - diagnosis (163) 163
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3237) 3237
Chinese (20) 20
French (5) 5
Japanese (3) 3
Russian (3) 3
Croatian (1) 1
Norwegian (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast cancer research : BCR, ISSN 1465-542X, 09/2013, Volume 15, Issue 5, pp. R84 - R84
Introduction: Estimates of the proportion of estrogen receptor negative (ERN) and triple-negative (TRN... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Receptors | Breast cancer | Epidemiology | Estrogen | Index Medicus
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 05/2015, Volume 125, Issue 5, pp. 1801 - 1814
.... In multiple breast cancer cohorts, MEL-18 was markedly downregulated in triple-negative breast cancer (TNBC... 
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Neoplasms, Hormone-Dependent - metabolism | Neoplasms, Hormone-Dependent - mortality | Estrogens | Humans | Drug Resistance, Neoplasm | Sp1 Transcription Factor - metabolism | Receptors, Progesterone - genetics | Polycomb Repressive Complex 1 - genetics | RNA, Messenger - biosynthesis | Receptors, Progesterone - analysis | Carcinoma, Ductal, Breast - drug therapy | Estrogen Receptor alpha - analysis | Carcinoma, Ductal, Breast - pathology | Neoplasm Proteins - genetics | Carcinoma, Ductal, Breast - metabolism | Cysteine Endopeptidases | Endopeptidases - metabolism | Triple Negative Breast Neoplasms - mortality | Breast Neoplasms - drug therapy | Estrogen Receptor alpha - genetics | Polycomb Repressive Complex 1 - physiology | RNA, Neoplasm - biosynthesis | RNA, Neoplasm - genetics | Biomarkers, Tumor - genetics | Estrogen Receptor alpha - biosynthesis | Mice | Neoplasm Proteins - deficiency | Proteasome Endopeptidase Complex - metabolism | Receptor, ErbB-2 - analysis | Neoplasm Transplantation | Neoplasm Proteins - physiology | Triple Negative Breast Neoplasms - drug therapy | Carcinoma, Ductal, Breast - mortality | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Polycomb Repressive Complex 1 - deficiency | Sumoylation - drug effects | Protein Processing, Post-Translational - drug effects | Antineoplastic Agents, Hormonal - therapeutic use | Triple Negative Breast Neoplasms - pathology | Female | Aminopyridines - administration & dosage | Antineoplastic Agents, Hormonal - pharmacology | Morpholines - administration & dosage | RNA, Messenger - genetics | Kaplan-Meier Estimate | Proportional Hazards Models | Tumor Suppressor Protein p53 - metabolism | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoplasms, Hormone-Dependent - pathology | Triple Negative Breast Neoplasms - metabolism | Tamoxifen - therapeutic use | Tamoxifen - pharmacology | Breast Neoplasms - mortality | Neoplasms, Hormone-Dependent - drug therapy | Progesterone | Biomarkers, Tumor - biosynthesis | Receptors, Progesterone - biosynthesis | Index Medicus | Abridged Index Medicus | Oncology | Endocrinology
Journal Article
Annals of oncology, ISSN 0923-7534, 08/2012, Volume 23, Issue 6, pp. vi7 - vi12
Journal Article
Journal Article
Molecular cancer, ISSN 1476-4598, 03/2017, Volume 16, Issue 1, pp. 57 - 57
Journal Article